🔎 Trials Near Me

Dachaigh › Galar Ae Steatotic › Missouri

Sgrùdaidhean clionaigeach Galar Ae Steatotic ann an Missouri

Tha 14 sgrùdaidhean airson Galar Ae Steatotic a’ lorg phàirtichean aig làraichean ann an Missouri.

Bailtean ann an Missouri

Teacsa sgrùdaidh oifigeil (Beurla)

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

  • 89bio Clinical Study Site, St Louis
  • 89bio Clinical Study Site, St Louis
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

  • 89bio Clinical Study Site, St Louis
A’ fastadhÌre 3
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06318169

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

  • Washington University School of Medicine, St Louis
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  • AMR Clinical, Kansas City
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

  • Akero Clinical Study Site, Columbia
  • Akero Clinical Study Site, Kansas City
  • Akero Clinical Study Site, St Louis
  • agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

  • GSK Investigational Site, Springfield
  • GSK Investigational Site, St Louis
  • GSK Investigational Site, St Louis
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07221188

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

  • Gastrointestinal Associates, Columbia
  • Gateway GI Research, LLC, St Louis
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07288138

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)

  • University of Missouri School of Medicine, Columbia
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT06571474

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity

  • University of Missouri School of Medicine, Columbia
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT06335771

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

  • GSK Investigational Site, Kansas City
  • GSK Investigational Site, Springfield
  • GSK Investigational Site, St Louis
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

  • GSK Investigational Site, Kansas City
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 8 Iuch 2026 · NCT06920043

Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans

  • Harry S. Truman Memorial, Columbia, MO, Columbia
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 19 Gearr 2026 · NCT05526144

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.